CTOs on the Move

Se2 Spielman Engineering

www.se2-engineering.com

 
Se2 Spielman Engineering is a Camarillo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Burke County Hospital Auxiliary, Inc

Burke County Hospital Auxiliary, Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Waynesboro, GA. To find more information about Burke County Hospital Auxiliary, Inc, please visit www.burkemedical.net

International Medical Equipment

International Medical Equipment, Inc. is a San Marcos, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Northside Anesthesiology Consultants

Northside Anesthesiology Consultants is a Roswell, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Community Healthcare Network of New York

Community Healthcare Network of New York is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Community Healthcare Network of New York is based in New York, NY. You can find more information on Community Healthcare Network of New York at www.chnnyc.org

Mela Sciences

At MELA Sciences, we design and develop innovative software-driven medical technologies for physician clinical use during the detection of skin cancers at the most curable and cost-effective stages. Our mission is to develop breakthrough medical technologies to improve skin cancer detection and achieve better outcomes for all. We envision a world in which our pioneering innovations will change the way patients think about skin cancer, while providing dermatologists and clinicians with new, effective, non-invasive tools for the earliest detection possible. MELA Sciences conducted the largest, positive prospective study ever done on the melanoma disease, and is the first and only medical technology company to receive both FDA Pre-Market Approval (PMA) for the U.S. and CE Marking certification for the European Union for a device of this nature. The company’s flagship product, MelaFind®, is intended to provide dermatologists with software-driven image analysis of clinically atypical pigmented skin lesions when they choose to obtain additional information to help decide whether to biopsy or not. The FDA has approved MELA Sciences’ MelaFind® Pre-Market Approval application for use in the United States and MELA Sciences has also been granted CE Mark approval for sale of MelaFind® in the European Union.